Finesse Sharkskin
Payments companies reported to CMS as associated with Finesse Sharkskin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Finesse Sharkskin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Finesse Sharkskin
These are the largest totals companies reported as associated with Finesse Sharkskin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lejla Vajzovic | Durham, NC | Ophthalmology | $13,616.60 |
| Mrinali Gupta | New York, NY | Ophthalmology | $13,553.29 |
| Eric Nudleman | San Diego, CA | Ophthalmology | $13,376.73 |
| David Almeida | Erie, PA | Ophthalmology | $13,069.74 |
| Jayanth Sridhar | Miami, FL | Ophthalmology | $12,802.49 |
| Samuel Houston III | Orlando, FL | Ophthalmology | $12,489.75 |
| Audina Berrocal | Miami, FL | Retina Specialist | $12,342.30 |
| Rishi Singh | Boston, MA | Ophthalmology | $12,305.40 |
| Yoshihiro Yonekawa | Plymouth Meeting, PA | Ophthalmology | $12,143.26 |
| Yannek Leiderman | Chicago, IL | Ophthalmology | $9,364.01 |
Prescribed Finesse Sharkskin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.